KDOQI (Kidney Disease Outcomes Quality Initiative)
NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target


TABLES

Table 1.

Ongoing Randomized Controlled Trials on Hemoglobin Targets in Adult
Patients with CKD Identified from Clinicaltrials.gov

Table 2.

Summary Table of RCTs Comparing Different Hb Targets on Key
Clinical Outcomes in the HD-CKD and PD-CKD Populations

Table 3.

Summary Table of RCTs Comparing Different Hb Targets on Quality
of Life in the HD-CKD and PD-CKD Populations

Table 4.

Summary Table of RCTs Comparing Different Hb Targets on
Non-CVD/Mortality Adverse Event Rates in the HD-CKD and PD-CKD Populations

Table 5.

Summary Table of RCTs Comparing Different Hb Targets on
Exercise Capacity in the HD-CKD and PD-CKD Populations

Table 6.

Evidence Matrix of Study Quality by Outcome for RCTs Comparing
Different Hb Targets in the HD-CKD and PD-CKD Populations

Table 7.

Evidence Profile of RCTs Comparing Different Hb Targets in the
HD-CKD and PD-CKD Populations

Table 8.

Summary Table of RCTs Comparing Different Hb Targets on Key
Clinical Outcomes in the ND-CKD Population

Table 9.

Summary Table of RCTs Comparing Different Hb Targets on Quality
of Life in the ND-CKD Population

Table 10.

Summary Table of RCTs Comparing Different Hb Targets
on Non-CVD/Mortality Adverse Event Rates in the ND-CKD Population

Table 11.

Evidence Matrix of Study Quality by Outcome for RCTs Comparing
Different Hb Targets in the ND-CKD Population

Table 12.

Evidence Profile of RCTs Comparing Different Hb Targets in the
ND-CKD Population

Table 13.

Consideration for Appraisal of Surrogate Outcome Trials

Table 14.

Grading of Study Quality

Table 15.

GRADE System for Grading Quality of Evidence

Table 16.

Strength of Guideline Recommendations, Consensus-Based Statements, and
Linkage to Quality of Evidence

FIGURES

Figure 1.

Randomized Controlled Trials Comparing Lower with Higher Hemoglobin (Hb)
Target Levels

Figure 2.

Relative Mortality Risk for Assignment to Higher Hemoglobin (Hb) Treatment
Targets in Patients with Nondialysis Chronic Kidney Disease

Figure 3.

Relative Risk of Adverse Cardiovascular Events for Assignment to Higher
Hemoglobin (Hb) Treatment Target in Patients with Nondialysis Chronic
Kidney Disease

Figure 4.

Relative Mortality Risk for Assignment to Higher Hemoglobin (Hb) Treatment
Target in Patients with Chronic Kidney Disease Undergoing Dialysis

Figure 5.

Relative Risk of Adverse Cardiovascular Events for Assignment to Higher
Hemoglobin (Hb) Treatment Target in Patients with Chronic Kidney Disease
Undergoing Dialysis

 

Back to top | Main Page